Business & Development
-
M&G appoints Chris Hudson to lead its UK distribution growth ambitions, including £62 billion flagship PruFund range
M&G’s Life Insurance Business today announces the appointment of Chris Hudson as Director of Distribution, as the firm ramps up its ambitions…
-
UK businesses leading the way with record numbers of female leaders and board members
Top British companies are continuing to lead the way for gender equality in boardrooms with women occupying nearly 43% of roles on…
-
7IM expands service team further with Business Development Manager for the Northwest
7IM has appointed Nicky Snow as Business Development Manager for the Northwest to reinforce its support for advisers in the region and…
-
Nikko AM: Did DeepSeek cause an AI paradigm shift? The implications of a small Chinese startup’s low cost chatbot on the global AI sector
Not too long ago, the term artificial intelligence (AI) was found only in the realm of science fiction novels. It was featured…
-
Jefferies upgrades GSK to ‘buy’, cuts AstraZeneca to ‘hold’
(Sharecast News) – Jefferies has upgraded its rating on GlaxoSmithKline to ‘buy’ and cut AstraZeneca to ‘hold’ as part of its review…
-
RBC Capital cuts Rentokil price target
(Sharecast News) – RBC Capital Markets cut its price target on Rentokil Initial on Wednesday to 575p from 610p as it downgraded…
-
Citi stays cautious about Experian on falling US credit flows
(Sharecast News) – Citi has lifted its target price for data analytics and consumer credit reporting group Experian after a near-30% jump…
-
JP Morgan sees no upside at Softcat despite share-price weakness
(Sharecast News) – JP Morgan has reiterated its ‘underweight’ rating on Softcat following investor feedback on its recent downgrade, saying that the…
-
Apple shares hit by downgrade on iPhone 15 disappointment
(Sharecast News) – Apple futures were falling sharply on Tuesday morning after analysts at Barclays cut their rating on the stock from…
-
AstraZeneca to buy Gracell Technologies for $1.2bn
(Sharecast News) – AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the…
Wealth DFM Talk is our flagship podcast, that fits perfectly into your busy life, bringing the latest insight, analysis, news and interviews to you, wherever you are.
Wealth DFM Talk Podcast – listen to the latest episode
